Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Strong Performer, Under Radar
1191.2000 10.30 (0.87%)
NSE May 27, 2025 15:31 PM
Volume: 2.5M
High volume today

logo
Aurobindo Pharma Ltd.
06 Jun 2016
1191.20
0.87%
Economic Times
The company paid its CEO, M Govindarajan, an average annual compensation of Rs 9.5 crore, which is above the average CEO salary during the period.
Promoters unpledged 0.91% of shares in last quarter. Total pledge stands at 16.92% of promoter holdings
Aurobindo Pharma gets best value from payout to CEO in 3 years
Economic Times | 06 Jun 2016
More from Aurobindo Pharma Ltd.
Recommended
Five stocks to buy from analysts this week - May 27, 2025
The Baseline | 27 May 2025, 05:44PM
Market closes lower, Bondada Engineering bags a Rs 204 crore order in Telangana
Trendlyne Marketwatch | 27 May 2025, 04:01PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020